Literature DB >> 4893886

A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.

J A Jensen.   

Abstract

A material which specifically inactivates mammalian C'4 was isolated from low ionic strength precipitates of nurse shark serum. The C'4 inactivator was not detected in whole serum. The conditions of its generation and its immunoelectrophoretic behavior seem to indicate that it is an enzymatically formed cleavage product of a precursor contained in whole shark serum. The inactivator was partially purified and characterized. It had an S-value of 3.3 (sucrose gradient) which was in agreement with its retardation on gel filtration, was stable between pH 5.0 and 10.0, had a half-life of 5 min at 56 degrees C, pH 7.5, was inactivated by trypsin and was nontoxic. Its powerful anticomplementary activity in vitro and in vivo was solely due to the rapid inactivation of C'4; no other complement components were affected. No cofactor requirement was observed for the equally rapid inactivation of highly purified human and guinea pig C'4. The kinetics of C'4 inactivation and TAME hydrolysis, the greater anodic mobility of inactivated human C'4, and the influence of temperature on the rate of inactivation suggest that the inactivator is an enzyme and C'4 its substrate. This conclusion was supported by the more recent detection of a split product of C'4. Intravenous administration of the C'4 inactivator could prevent lethal Forssman shock and suppress the Arthus reaction in guinea pigs; it prolonged significantly the rejection time of renal xenografts but had no detectable effect on passive cutaneous anaphylaxis. Anaphylatoxin could be generated in C'4 depleted guinea pig serum with the cobra venom factor, but not with immune precipitates. The possible relationship between C'1 esterase and the C'4 inactivator is discussed on the basis of similarities and dissimilarities.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4893886      PMCID: PMC2138682          DOI: 10.1084/jem.130.2.217

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Partial purification of a serum inhibitor of C'1-esterase.

Authors:  J PENSKY; L R LEVY; I H LEPOW
Journal:  J Biol Chem       Date:  1961-06       Impact factor: 5.157

2.  Interaction of a serum inhibitor of C'I-esterase with intermediate complexes of the immune haemolytic system. I. Specificity of inhibition of C'I activity associated with intermediate complexes.

Authors:  I H LEPOW; M A LEON
Journal:  Immunology       Date:  1962-03       Impact factor: 7.397

3.  [Decomplementization by a factor extracted from cobra venom. Effect on several immune reactions of the guinea pig and rat].

Authors:  J L Maillard; R M Zarco
Journal:  Ann Inst Pasteur (Paris)       Date:  1968-06

4.  The relationship of the hemolytic activity of active C'1s to its TAMe esterase action: a new method of purification and assay.

Authors:  K Nagaki; R M Stroud
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

5.  Renal xenograft prolongation by suppression of natural antibody.

Authors:  B S Linn; J A Jennsen; P Portal; G B Snyder
Journal:  J Surg Res       Date:  1968-05       Impact factor: 2.192

6.  Prolongation of renal xenografts by complement suppression.

Authors:  G B Snyder; E Ballesteros; R M Zarco; B S Linn
Journal:  Surg Forum       Date:  1966

7.  Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.

Authors:  N Tamura; R A Nelson
Journal:  J Immunol       Date:  1967-09       Impact factor: 5.422

8.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

9.  Anaphylatoxin in its relation to the complement system.

Authors:  J Jensen
Journal:  Science       Date:  1967-03-03       Impact factor: 47.728

10.  Some properties of an esterase derived from preparations of the first component of complement.

Authors:  O D RATNOFF; I H LEPOW
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307

  10 in total
  14 in total

1.  Isolation of C4-synthesizing cells from guinea-pig liver by Ficoll density gradient centrifugation.

Authors:  C L Ilgen; P M Burkholder
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

2.  Role of complement system in the endotoxicity-enhancing and endotoxin-detoxifying effect of serum.

Authors:  G Füst; G Fóris
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

3.  Neutralization of sensitized virus by purified components of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

4.  Heterophile antibodies and tissue injury. 1. Ultrastructure of pulmonary vascular lesions produced by Forssman antiserum in guinea-pigs.

Authors:  N S Taichman; M Creighton; A Stephenson; C C Tsai
Journal:  Immunology       Date:  1972-01       Impact factor: 7.397

5.  Heterophile antibodies and tissue injury. 3. A role for platelets in the development of lethal vascular injury during Forssman shock in guinea pigs.

Authors:  C C Tsai; N S Taichman; W H Pulver; E Schönbaum
Journal:  Am J Pathol       Date:  1973-08       Impact factor: 4.307

6.  The role of the sixth component of complement in the rejection of kidney xenografts.

Authors:  J E Mejía-Laguna; M García-Cornejo; F Lopez-Soriano; C E Biro
Journal:  Immunology       Date:  1970-11       Impact factor: 7.397

7.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors:  R Snyderman; M C Pike
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Prolonged survival of kidney xenografts in leucopenic rabbits.

Authors:  J E Mejía-Laguna; A Martínez-Palomo; F López-Soriano; M García-Cornjeo; C E Biro
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

9.  Specific inactivation of the fourth complement component. I. In vivo studies.

Authors:  J A Jensen; M C Garces; E Iglesias
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

10.  Delayed rejection of cardiac xenografts in C6-deficient rabbits.

Authors:  C C O'Regan; P Robitaille; M Pinto-Blonde; C Chartrand
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.